Annual Cash & Cash Equivalents
$7.79 M
+$3.70 M+90.37%
December 31, 2023
Summary
- As of February 8, 2025, CRVO annual cash & cash equivalents is $7.79 million, with the most recent change of +$3.70 million (+90.37%) on December 31, 2023.
- During the last 3 years, CRVO annual cash & cash equivalents has fallen by -$10.72 million (-57.91%).
- CRVO annual cash & cash equivalents is now -79.12% below its all-time high of $37.31 million, reached on December 1, 2021.
Performance
CRVO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$7.74 M
-$2.27 M-22.63%
September 30, 2024
Summary
- As of February 8, 2025, CRVO quarterly cash and cash equivalents is $7.74 million, with the most recent change of -$2.27 million (-22.63%) on September 30, 2024.
- Over the past year, CRVO quarterly cash and cash equivalents has increased by +$1.37 million (+21.58%).
- CRVO quarterly cash and cash equivalents is now -83.40% below its all-time high of $46.63 million, reached on March 1, 2021.
Performance
CRVO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRVO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +90.4% | +21.6% |
| 3 y3 years | -57.9% | +21.6% |
| 5 y5 years | -2.5% | +21.6% |
CRVO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.1% | +90.4% | -79.3% | +89.2% |
| 5 y | 5-year | -79.1% | +90.4% | -83.4% | +89.2% |
| alltime | all time | -79.1% | -100.0% | -83.4% | -100.0% |
CervoMed Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.74 M(-22.6%) |
| Jun 2024 | - | $10.01 M(+57.2%) |
| Mar 2024 | - | $6.37 M(-18.3%) |
| Dec 2023 | $7.79 M(+90.4%) | $7.79 M(-25.2%) |
| Sep 2023 | - | $10.42 M(-30.5%) |
| Jun 2023 | - | $15.00 M(+2.4%) |
| Mar 2023 | - | $14.65 M(+257.8%) |
| Dec 2022 | $4.09 M(-89.0%) | - |
| Dec 2022 | - | $4.09 M(-37.9%) |
| Sep 2022 | - | $6.59 M(+10.4%) |
| Jun 2022 | - | $5.97 M(-39.6%) |
| Mar 2022 | - | $9.87 M(-73.5%) |
| Dec 2021 | $37.31 M(+101.5%) | $37.31 M(-7.5%) |
| Sep 2021 | - | $40.34 M(-6.9%) |
| Jun 2021 | - | $43.31 M(-7.1%) |
| Mar 2021 | - | $46.63 M(+151.9%) |
| Dec 2020 | $18.52 M(+30.6%) | $18.52 M(-15.5%) |
| Sep 2020 | - | $21.91 M(-14.3%) |
| Jun 2020 | - | $25.56 M(+136.1%) |
| Mar 2020 | - | $10.83 M(-23.6%) |
| Dec 2019 | $14.18 M(+77.4%) | $14.18 M(+130.9%) |
| Sep 2019 | - | $6.14 M(-26.7%) |
| Jun 2019 | - | $8.37 M(+57.0%) |
| Mar 2019 | - | $5.33 M(-33.3%) |
| Dec 2018 | $7.99 M(-10.2%) | $7.99 M(-27.5%) |
| Sep 2018 | - | $11.02 M(-14.8%) |
| Jun 2018 | - | $12.93 M(-20.2%) |
| Mar 2018 | - | $16.20 M(+82.1%) |
| Dec 2017 | $8.90 M(+472.9%) | $8.90 M(+631.6%) |
| Sep 2017 | - | $1.22 M(-83.6%) |
| Jun 2017 | - | $7.41 M(-39.3%) |
| Mar 2017 | - | $12.21 M(+686.4%) |
| Dec 2016 | $1.55 M | $1.55 M(-48.6%) |
| Sep 2016 | - | $3.02 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $3.01 M(-48.8%) |
| Mar 2016 | - | $5.87 M(+193.7%) |
| Dec 2015 | $2.00 M(-90.9%) | $2.00 M(-86.3%) |
| Sep 2015 | - | $14.58 M(-11.5%) |
| Jun 2015 | - | $16.47 M(-14.2%) |
| Mar 2015 | - | $19.21 M(-12.2%) |
| Dec 2014 | $21.88 M(+8481.9%) | $21.88 M(-8.0%) |
| Sep 2014 | - | $23.79 M(-12.3%) |
| Jun 2014 | - | $27.14 M(>+9900.0%) |
| Mar 2014 | - | $222.10 K(-12.9%) |
| Dec 2013 | $255.00 K(-18.3%) | $255.00 K(-0.2%) |
| Sep 2013 | - | $255.60 K(+225.2%) |
| Jun 2013 | - | $78.60 K(-29.4%) |
| Mar 2013 | - | $111.40 K(-64.3%) |
| Dec 2012 | $312.10 K(+217.2%) | $312.10 K(+98.9%) |
| Sep 2012 | - | $156.90 K(+265.7%) |
| Jun 2012 | - | $42.90 K(+225.0%) |
| Mar 2012 | - | $13.20 K(-86.6%) |
| Dec 2011 | $98.40 K(>+9900.0%) | $98.40 K(-95.4%) |
| Sep 2011 | - | $2.13 M(-63.7%) |
| Jun 2011 | - | $5.87 M(>+9900.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2010 | - | $13.00 K(-77.7%) |
| Jun 2010 | - | $58.30 K(-87.5%) |
| Mar 2010 | - | $465.50 K(>+9900.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(-100.0%) |
| Jun 2009 | - | $200.20 K(>+9900.0%) |
| Mar 2009 | - | $200.00(-75.0%) |
| Dec 2008 | $800.00(+300.0%) | $800.00(-70.4%) |
| Sep 2008 | - | $2700.00(-83.4%) |
| Jun 2008 | - | $16.30 K(+8050.0%) |
| Dec 2007 | $200.00(-99.4%) | $200.00 |
| Dec 1999 | $33.70 K | - |
FAQ
- What is CervoMed annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CervoMed?
- What is CervoMed annual cash & cash equivalents year-on-year change?
- What is CervoMed quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CervoMed?
- What is CervoMed quarterly cash and cash equivalents year-on-year change?
What is CervoMed annual cash & cash equivalents?
The current annual cash & cash equivalents of CRVO is $7.79 M
What is the all time high annual cash & cash equivalents for CervoMed?
CervoMed all-time high annual cash & cash equivalents is $37.31 M
What is CervoMed annual cash & cash equivalents year-on-year change?
Over the past year, CRVO annual cash & cash equivalents has changed by +$3.70 M (+90.37%)
What is CervoMed quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRVO is $7.74 M
What is the all time high quarterly cash and cash equivalents for CervoMed?
CervoMed all-time high quarterly cash and cash equivalents is $46.63 M
What is CervoMed quarterly cash and cash equivalents year-on-year change?
Over the past year, CRVO quarterly cash and cash equivalents has changed by +$1.37 M (+21.58%)